CDK4/6 Inhibitors Effective in Mice Bearing Multiple Human Cancer Types
BOSTON – Cyclin-dependent kinase (CDK) inhibitors, including palbociclib, were effective against patient-derived xenograft (PDX) mouse models of different tumor...
BOSTON – Cyclin-dependent kinase (CDK) inhibitors, including palbociclib, were effective against patient-derived xenograft (PDX) mouse models of different tumor...
BOSTON – The investigational bispecific HER2/HER3 antibody therapeutic MCLA-128 showed radiological and clinical responses in patients with metastatic pancreatic...
BOSTON – The investigational therapeutic AG-270, which targets the protein MAT2A, was safe, tolerable, and showed signs of activity...
SAN FRANCISCO – Racial disparities in death rates from colorectal cancer vary considerably across cities in the United States,...
Study examined feasibility, potential benefits of collaboration SAN FRANCISCO – African American breast cancer patients who received second opinions...
SAN FRANCISCO – Among women in Chicago, African Americans and Hispanics were exposed to higher levels of ambient toxic...
SAN FRANCISCO – Most LGBTQI+ Latinx have been afraid to share their gender identity and/or sexual orientation with a...
SAN FRANCISCO – Medicare patients from lower socioeconomic groups and several ethnic minority groups were more likely than their...
SAN FRANCISCO – A culturally tailored intervention to improve human papillomavirus (HPV) screening among low-income Asian American women significantly...
SAN FRANCISCO – A nonengineered, multiantigen-specific T-cell therapy was safe, tolerable, and showed signs of clinical activity in patients...